The University of Arizona
Home Grand Rounds Bisphosphonate Associated Atypical Femoral Fractures

Bisphosphonate Associated Atypical Femoral Fractures


May 6, 2011

 

Michael Maricic, M.D.

Rheumatologist

Catalina Pointe Rheumatology

Tucson, AZ





Objectives
Participant should be able to:

1) Recognize the Major and Minor criteria for Atypical Femoral Fractures

2) Assess the incidence rates of bisphosphonate associated atypical femoral fractures

3) Discuss the diagnostic work up needed for patients with these fractures

 

Disclosure: Grant/Research Support/Consultant/Speakers Bureau:  Amgen, Lilly, Merck, Novartis, Proctor & Gamble.